Peter Ordentlich, Chief Scientific Officer at Syndax Pharmaceuticals Inc (SNDX), sold 50,000 shares at $25.04 ($1.3M) on 2022-08-24, disclosed to the SEC on 2022-08-26.
Open-market sale of $1.3M SNDX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.04 | 2,154 | $54K | 4.3% |
| 2 | $25.04 | 2,154 | $54K | 4.3% |
| 3 | $25.04 | 22,846 | $572K | 45.7% |
| 4 | $25.04 | 22,846 | $572K | 45.7% |
| Total | $25.04 avg | 50,000 | $1.3M | 100% |
| Filing → |
| SNDX | SELL | 2022-12-02 | $821K | — | Filing → |
| SNDX | SELL | 2022-02-03 | $24K | — | Filing → |
| SNDX | SELL | 2020-11-25 | $1.4M | — | Filing → |